Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 3/2018

Open Access 01-03-2018 | Original Article

Influence of cancer and acute inflammatory disease on taste perception: a clinical pilot study

Authors: P. Schalk, M. Kohl, H. J. Herrmann, R. Schwappacher, M. E. Rimmele, A. Buettner, J. Siebler, M. F. Neurath, Y. Zopf

Published in: Supportive Care in Cancer | Issue 3/2018

Login to get access

Abstract

Purpose

Cancer patients are at high risk of malnutrition and tumor cachexia further increasing morbidity and mortality. Reasons for cachexia are not clear yet, but inflammatory processes as well as the occurrence of taste disorders reducing nutrient uptake are discussed to play key roles. The purpose of this study was to gain insight into causative factors of taste disturbance in cancer patients. Does the cancer itself, inflammatory processes or cancer therapy influence taste disorders?

Methods

To capture an underlying taste disorder patients with cancer (n = 42), acutely hospitalized inflammatory disease patients (n = 57) and healthy controls (n = 39) were examined. To assess the influence of chemotherapy, patients with and without chemotherapy were compared. Taste tests were performed according to DIN ISO 3972:2011. Inflammation was recorded using laboratory parameters. Statistical evaluation was conducted using the Software R.

Results

Cancer patients showed significantly increased taste thresholds for sweet, salty, and umami compared to healthy controls. There were no significant differences in taste detection and recognition between patients with former, current, or without chemotherapeutical treatment. Patients with an acute inflammatory disease showed an increased taste threshold for umami compared to healthy controls.

Conclusions

It could be shown that cancer patients suffer from taste disorders irrespective of an existing chemotherapeutical treatment. Cancer-related inflammation appears to have a greater impact on taste perception than an acute inflammatory process. Therefore, an adapted dietary adjustment should be carried out at an early stage for cancer patients in order to avoid nutritional disorders caused by a taste disorder.
Literature
1.
Laviano A, Koverech A, Mari A (2015) Cachexia: clinical features when inflammation drives malnutrition. Proc Nutr Soc 74(4):348–354CrossRef
2.
Delano MJ, Moldawer LL (2006) The origins of cachexia in acute and chronic inflammatory diseases. Nutr Clin Pract 21(1):68–81CrossRef
3.
Pressoir M et al (2010) Prevalence, risk factors and clinical implications of malnutrition in French comprehensive cancer centres. Br J Cancer 102(6):966–971CrossRef
4.
Maheswaran T et al (2014) Gustatory dysfunction. J Pharm Bioallied Sci 6(Suppl 1):S30–S33CrossRef
5.
Toffanello ED et al (2013) Taste loss in hospitalized multimorbid elderly subjects. Clin Interv Aging 8:167–174CrossRef
6.
Holmes S (1993) Food avoidance in patients undergoing cancer chemotherapy. Support Care Cancer 1(6):326–330CrossRef
7.
Feng P et al (2015) Regulation of bitter taste responses by tumor necrosis factor. Brain Behav Immun 49:32–42CrossRef
8.
Zopf Y et al (2009) Alterations of taste perception in Crohn’s disease and their dependency on disease activity and nutritional behavior. J Clin Gastroenterol 43(7):617–621CrossRef
9.
Boltong A et al (2014) A prospective cohort study of the effects of adjuvant breast cancer chemotherapy on taste function, food liking, appetite and associated nutritional outcomes. PLoS One 9(7):e103512CrossRef
10.
Vaughan VC, Martin P, Lewandowski PA (2013) Cancer cachexia: impact, mechanisms and emerging treatments. J Cachexia Sarcopenia Muscle 4(2):95–109CrossRef
11.
Zabernigg A et al (2010) Taste alterations in cancer patients receiving chemotherapy: a neglected side effect? Oncologist 15(8):913–920CrossRef
12.
Zopf Y, Herrmann HJ (2016) Principles of cachexia in tumor patients. Onkologe 22(4):8CrossRef
13.
Berteretche MV et al (2004) Decreased taste sensitivity in cancer patients under chemotherapy. Support Care Cancer 12(8):571–576CrossRef
14.
Steinbach S et al (2009) Qualitative and quantitative assessment of taste and smell changes in patients undergoing chemotherapy for breast cancer or gynecologic malignancies. J Clin Oncol 27(11):1899–1905CrossRef
15.
Sandow PL, Hejrat-Yazdi M, Heft MW (2006) Taste loss and recovery following radiation therapy. J Dent Res 85(7):608–611CrossRef
16.
Jensen SB et al (2008) Oral mucosal lesions, microbial changes, and taste disturbances induced by adjuvant chemotherapy in breast cancer patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106(2):217–226CrossRef
17.
Squier CA, Kremer MJ (2001) Biology of oral mucosa and esophagus. J Natl Cancer Inst Monogr 29:7–15CrossRef
18.
Boltong A, Keast R (2012) The influence of chemotherapy on taste perception and food hedonics: a systematic review. Cancer Treat Rev 38(2):152–163CrossRef
19.
Welge L et al (2004) Schmeckstörungen—Ursachen. Diagnostik und Therapie Therapeutische Umschau 61(5):302–307
20.
Boltong A, Keast RS, Aranda SK (2011) A matter of taste: making the distinction between taste and flavor is essential for improving management of dysgeusia. Support Care Cancer 19(4):441–442CrossRef
21.
Mojet J, Christ-Hazelhof E, Heidema J (2001) Taste perception with age: generic or specific losses in threshold sensitivity to the five basic tastes? Chem Senses 26(7):845–860CrossRef
22.
Thomas, L.V. and J. Delves-Broughton, PRESERVATIVES | Permitted Preservatives—Sorbic Acid, in Encyclopedia of Food Microbiology (Second Edition), C.A.B.L. Tortorello, Editor. 2014, Academic Press: Oxford p 102-107
23.
DIN Deutsches Institut für Normung e. V., DIN ISO 3972:2012–07. 2012
24.
Mojet J, Köster EP, Prinz JF (2005) Do tastants have a smell? Chem Senses 30(1):9–21CrossRef
25.
Yamauchi, Y., et al., A new whole-mouth gustatory test procedure. 1. Thresholds and principal components analysis in healthy men and women. Acta Otolaryngol Suppl, 2002(546): p. 39–48
26.
Epstein JB, Smutzer G, Doty RL (2016) Understanding the impact of taste changes in oncology care. Support Care Cancer 24(4):1917–1931CrossRef
27.
R CoreTeam (2017) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna
28.
Wang H et al (2009) Inflammation and taste disorders: mechanisms in taste buds. Ann N Y Acad Sci 1170:596–603CrossRef
29.
Cohn ZJ et al (2010) Lipopolysaccharide-induced inflammation attenuates taste progenitor cell proliferation and shortens the life span of taste bud cells. BMC Neurosci 11:72CrossRef
30.
Yeh DW et al (2016) Interplay between inflammation and stemness in cancer cells: the role of toll-like receptor signaling. J Immunol Res 2016:4368101CrossRef
31.
Jpma I I et al., Metallic taste in cancer patients treated with chemotherapy. Cancer Treat Rev, 2015. 41(2): p. 179–86
32.
Gamper EM et al (2012) Coming to your senses: detecting taste and smell alterations in chemotherapy patients. A systematic review. J Pain Symptom Manag 44(6):880–895CrossRef
33.
Barlow LA (2015) Progress and renewal in gustation: new insights into taste bud development. Development 142(21):3620–3629CrossRef
34.
Feng P, Huang L, Wang H (2014) Taste bud homeostasis in health, disease, and aging. Chem Senses 39(1):3–16CrossRef
35.
Lynch, K.E., et al., Altered taste perception and nutritional status among hemodialysis patients. J Ren Nutr, 2013. 23(4): p. 288–295.e1
36.
Tanriverdi O (2014) A discussion of serum albumin level in advanced-stage hepatocellular carcinoma: a medical oncologist’s perspective. Med Oncol 31(11):282CrossRef
37.
Tsutsumi R et al (2014) Albumin-normalized serum zinc: a clinically useful parameter for detecting taste impairment in patients undergoing dialysis. Nutr Res 34(1):11–16CrossRef
38.
de Araujo IE et al (2003) Representation of umami taste in the human brain. J Neurophysiol 90(1):313–319CrossRef
39.
Mouritsen OG (2012) Umami flavour as a means of regulating food intake and improving nutrition and health. Nutr Health 21(1):56–75CrossRef
40.
Masic U, Yeomans MR (2014) Monosodium glutamate delivered in a protein-rich soup improves subsequent energy compensation. J Nutr Sci 3:e15CrossRef
41.
Uneyama H et al (2009) Contribution of umami taste substances in human salivation during meal. J Med Investig 56(Suppl):197–204CrossRef
42.
Ahne G et al (2000) Assessment of gustatory function by means of tasting tablets. Laryngoscope 110(8):1396–1401CrossRef
43.
Hummel, T., B.N. Landis, and K.B. Huttenbrink, Smell and taste disorders. GMS Curr Top Otorhinolaryngol Head Neck Surg, 2011. 10: p. Doc04
44.
Henkin RI, Gill JR Jr, Bartter FC (1963) Studies on taste thresholds in normal man and in patients with adrenal cortical insufficiency: the role of adrenal cortical steroids and of serum sodium concentration. J Clin Invest 42(5):727–735CrossRef
45.
Schiffman SS et al (2007) Combination of flavor enhancement and chemosensory education improves nutritional status in older cancer patients. J Nutr Health Aging 11(5):439–454PubMed
Metadata
Title
Influence of cancer and acute inflammatory disease on taste perception: a clinical pilot study
Authors
P. Schalk
M. Kohl
H. J. Herrmann
R. Schwappacher
M. E. Rimmele
A. Buettner
J. Siebler
M. F. Neurath
Y. Zopf
Publication date
01-03-2018
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 3/2018
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-017-3898-y

Other articles of this Issue 3/2018

Supportive Care in Cancer 3/2018 Go to the issue

Original Article

As if the disease was not enough: coping with the financial consequences of cancer

Review Article

Barriers and facilitators of exercise experienced by cancer survivors: a mixed methods systematic review

Review Article

Genetics in palliative oncology: a missing agenda? A review of the literature and future directions

OriginalPaper

Accessing support before or after a parent dies from cancer and young people’s current wellbeing

Original Article

Relationship between phase I study duration and symptom burden

Commentary

Employer’s management of employees affected by cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits